欢迎来到天天文库
浏览记录
ID:53024686
大小:481.90 KB
页数:6页
时间:2020-04-12
《奥沙利铂致外周神经毒性症状特性及变化趋势的纵向研究-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、护理学杂志2014年9月第29卷第17期·1··重点关注肿瘤护理专题··论著·奥沙利铂致外周神经毒性症状特性及变化趋势的纵向研究丁彩艳,薛嵋,吴洪斌,陆箴琦摘要:目的探讨肠癌患者使用奥沙利铂期间外周神经毒性症状特性、变化趋势及非药物影响因素。方法对l13例使用奥沙利铂肠癌患者,采用神经毒性患者自述问卷(PNQ)于累积剂量达200mg/m、540mg/m、850mg/m时进行随访调查,评估外周神经毒性症状的严重度;Podo触觉测量笔及温度觉测量笔分别检测患者触觉及温度觉有无异常。结果首次使用奥沙利铂后88.5患者出现肢体感觉异常,首发表现以手部麻木为主,其次为刺痛。不同累积剂量时外周
2、神经毒性严重度比较,差异有统计学意义(均P3、014)17—0001一O6D0I:i0.3870/hlxzz.2014.17.0O1Longitudinalstudyonoxalip4、atininducedperipheralneuropathy:symptomfeaturesandchangingpattern//DingCaiyan,XueMei,WuHongbin,L“Zhenqi//(DepartmentofNursing,CancerHospitalofFudanUniversity,Shanghai200032,China)Abstract:0bjectiveTodescribesymptomfeatures,ch5、angingpattern,andnon—pharmacologicalfactorsofoxaliplatininducedpe—ripheralneuropathy.MethodsOnehundredandthirteencolorectalcancerpatientsreceivingoxaliplatin-basedchemotherapywereinvestigatedbyusingthePatientNeurotoxicityQuestionnairewhenthedoseofoxaliplatinwasaccumulatedtO200mg/m,540mg/m。,and6、850mg/m.TouchandtemperaturesensationweretestedwiththePodotouch—measuringpenandthetemperature—measuringpen.ResultsAbout88.5ofthepatientsexperiencedmeropresthesiaafterreceivingchemotherapyforthefirsttime.Theearlysymptomwasmainlyhandnumbness,followedbytingling.Significantdifferenceswerefoundinsev7、erityofperipheralneuro—pathyatdifferentaccumulateddosesandinpatientsusingdifferentadministrationmethodswhenthedoseaccumulatedto200rag/mand540mg/m(P<0.05,P<0.O1).Fourpatientshadimpairedtouchsensation.ConclusionThedamageofsensorynerveismorecommonandseverethanthemotornerveincolorectalcancerpatien8、tsreceivingoxaliplatin-basedchemotherapy,andthese—verityofneurotoxityisincreasedasthedoseaccumulated.WeshouldprovidetargetededucationandencouragepatientstOreceivemedicationthroughcentra1venouscatheters,SOastoavoidmeropresthesiainearlych
3、014)17—0001一O6D0I:i0.3870/hlxzz.2014.17.0O1Longitudinalstudyonoxalip
4、atininducedperipheralneuropathy:symptomfeaturesandchangingpattern//DingCaiyan,XueMei,WuHongbin,L“Zhenqi//(DepartmentofNursing,CancerHospitalofFudanUniversity,Shanghai200032,China)Abstract:0bjectiveTodescribesymptomfeatures,ch
5、angingpattern,andnon—pharmacologicalfactorsofoxaliplatininducedpe—ripheralneuropathy.MethodsOnehundredandthirteencolorectalcancerpatientsreceivingoxaliplatin-basedchemotherapywereinvestigatedbyusingthePatientNeurotoxicityQuestionnairewhenthedoseofoxaliplatinwasaccumulatedtO200mg/m,540mg/m。,and
6、850mg/m.TouchandtemperaturesensationweretestedwiththePodotouch—measuringpenandthetemperature—measuringpen.ResultsAbout88.5ofthepatientsexperiencedmeropresthesiaafterreceivingchemotherapyforthefirsttime.Theearlysymptomwasmainlyhandnumbness,followedbytingling.Significantdifferenceswerefoundinsev
7、erityofperipheralneuro—pathyatdifferentaccumulateddosesandinpatientsusingdifferentadministrationmethodswhenthedoseaccumulatedto200rag/mand540mg/m(P<0.05,P<0.O1).Fourpatientshadimpairedtouchsensation.ConclusionThedamageofsensorynerveismorecommonandseverethanthemotornerveincolorectalcancerpatien
8、tsreceivingoxaliplatin-basedchemotherapy,andthese—verityofneurotoxityisincreasedasthedoseaccumulated.WeshouldprovidetargetededucationandencouragepatientstOreceivemedicationthroughcentra1venouscatheters,SOastoavoidmeropresthesiainearlych
此文档下载收益归作者所有